Discover how Celliaz leverages Anti-PROX1 technology to unlock retinal regeneration and create new possibilities for patients with retinal diseases.
Retinal diseases gradually damage retinal cells, leading to irreversible vision loss and limited treatment options.
Unlike humans, zebrafish can naturally regenerate damaged retinal cells through Müller glia activation.
In the human retina, PROX1 accumulates around Müller glia cells and suppresses their regenerative activity after transferring into Müller glia.
PROX1-neutralizing antibodies bind PROX1 in the extracellular space and block PROX1 transfer to Müller glia.
In the absence of PROX1 transfer, Müller glia can recover theirregenerative potential and support retinal repair.
Watch how Celliaz’s anti-PROX1 technology unlocks the regenerative potential of the retina.